Alignment Health expands Medicare Advantage plan to Nye County for 2027

Expansion into Nye County begins January 1, 2027. Portfolio grows to six plans across three Nevada counties. Network supports over 6,500 physicians and major health systems. Specialized Heart & Diabetes plan offers up to $204 monthly allowance.

Alignment Healthcare faces BFA Law probe over alleged EBITDA manipulation

BFA Law investigates Alignment Healthcare for inflating adjusted EBITDA by $8-10 million. Misclassification allegedly turned a $7-9 million loss into $1.3 million profit in 2024. Stock dropped 16.7% on July 8, 2026, following whistleblower lawsuit reports. Shares fell another 13% on October 9, 2026, after CMS downgraded California HMO rating. Cumulative decline since July 30, 2026, reached ~59%, erasing $2.2 billion in market cap.

Alignment Health signs Astrana deal to expand CA senior care access

Alignment Health Plan partners with Astrana Health to expand in-network care for Medicare Advantage members in seven California counties starting January 1, 2027. Members gain access to Astrana’s network of 3,000 primary care providers and 6,500 specialists. The partnership specifically targets multilingual care, offering over 600 in-language primary care physicians for Chinese, Korean, and Vietnamese-speaking seniors. The service area covers regions home to more than 3.7 million Medicare beneficiaries.

Alignment Healthcare secures 4-star ratings in six of seven MA contracts

Six of seven eligible Medicare Advantage contracts earned 4 Stars or higher. Three plans achieved an overall 4.5-Star Rating across five states. California H3815 HMO contract received a 3.5-Star Rating, which Alignment disputes. Company plans to pursue administrative remedies and litigation for the disputed rating.

Hagens Berman probes Alignment Healthcare after 20% stock drop

Alignment Healthcare shares dropped nearly 20% on October 1, 2026, reaching a 52-week low. Hagens Berman updated its investigation following disclosures at the Baird Conference. Management revealed $10 million to $11 million in unexpected second-half investments. Whistleblower alleges misclassification of operating expenses as capital expenditures. Previous Q2 earnings miss on July 31, 2026, also triggered a >20% share decline.

Hagens Berman updates probe into Alignment Healthcare over Baird disclosures

Hagens Berman updates its investigation into Alignment Healthcare (ALHC) following a 19.8% stock drop on September 15, 2026. The decline followed management's disclosure of $10M-$11M in unexpected second-half investments and medical cost headwinds at the Baird Conference. Whistleblower allegations claim Alignment misclassified operating expenses as capital expenditures to inflate adjusted EBITDA for 2024 and 2025. Shares have fallen significantly since July 2026, with drops of 16.7%, over 20%, and 19.8% linked to earnings misses and new disclosures.